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The recent identification of an expanded role for vitamin D
action, beyond its traditional actions in mineral metabolism
and the novel investigational approaches as well, has opened
new therapeutic avenues for both the clinician at bedside and
the scientist. This is the rationale of dedicating a special issue
on this hot topic.
A new spectrum of vitamin D biological activities includ-
ing important aspects on cellular proliferation, differentia-
tion, and the immune system has been recently identified.
Relevant is also the interaction of vitamin D with other
kidney hormones such as renin and erythropoietin; this topic
is specifically addressed by this paper. Indeed, the adminis-
tration of vitamin D analogues has been associated with an
improvement in anaemia and reduction in erythropoiesis-
stimulating agents (ESA) requirements. Furthermore, vita-
minDdeficiency could contribute to the inappropriately acti-
vated or unsuppressed renin-angiotensin-aldosterone system
(RAAS) in pathologic conditions.
Experimental data show that vitaminDmay also interfere
with the compensatory increase in renin synthesis occurring
during chronic administration of anti-RAAS agents. In this
context, use of vitamin D may be therefore suggested in
patients treated with anti-RAAS but not reaching the safe
threshold level of proteinuria. As further support to the
hypothesis on the use of vitamin D analogues as antipro-
teinuric agents in proteinuric chronic kidney disease (CKD)
are the data evidencing its anti-inflammatory effects. In this
special issue, J. Egido et al. provided novel insights into the
association between vitamin D deficiency and the activation
of the RAAS, which is critical if one considers that local acti-
vation of this latter system mainly contributes to inflamma-
tion and tissue damage in renal diseases. Based on studies in
human kidney proximal tubular cells, the authors propose a
novel signalling pathway explaining, at least in part, the anti-
inflammatory effects of paricalcitol in chronic kidney dis-
ease (CKD). Indeed, they found that the anti-inflammatory
actions of paricalcitol may depend on the inhibition of TGF-
𝛼/ADAM17/EGFR pathway stimulated by aldosterone.
I. Guessous reviewed the role of vitamin D, as a marker of
health status rather than a predictor of health outcomes. He
analyzed the potential impact of currently ongoing random-
ized clinical trials (RCTs). The role of vitamin D in skeletal
complications is also questioned, since, according to recent
studies, vitamin D might not be as essential as previously
thought for maintaining bone health.
Observational data support a link between vitamin D
status and cardiovascular diseases, and vitamin D deficiency
can thus be considered a cardiovascular risk marker. Regard-
ing this issue, O. Marginean and I. Mozos discussed the
role of vitamin D in blood pressure control, left ventricular
hypertrophy, atrial fibrillation, the metabolic syndrome, and
peripheral artery disease. Genotyping for vitamin D receptor
variants could help to distinguish patients at risk of develop-
ing cardiovascular disease.
In a compelling review, P. Olivier et al. first describe the
trophic effect of vitamin D in the skeletal muscle. Hypovita-
minosis D is consistently associated with decrease in muscle
function and performance and increase in disability. Data
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from randomized controlled trials andmeta-analysis showed
that vitamin D supplementation improves muscle strength,
gait, and the risk of falls in different settings, especially in the
elderly frail patient.
G. Ferlazzo et al. review data from clinical and basic
research data on the role of vitamin D in inflammatory bowel
disease (IBD) with regard to immune regulation, VDR (vita-
min D receptor) polymorphism, disease activity and severity,
and outcomes.Despite the growing evidence suggesting a role
for vitaminD deficiency in the development of IBD, the exact
role of vitamin D in IBD is still unclear and merits further
investigation.
The article of P.Mansueto et al. focuses on themost recent
epidemiological and experimental data looking at relation-
ships between vitamin D and HIV infection. Clinical impli-
cations and potential benefits of vitamin D supplementation,
in this particular setting, are explored in this comprehensive
review.
Two papers in this issue discuss vitamin D in relation
with gynecological and obstetrics diseases. O. Triolo et al.
reviewed in detail the current knowledge of the association
between VDR-mediated signalling pathways and vitamin
D levels in polycystic ovary syndrome, endometriosis, and
ovarian and breast cancer as well as in pathologies related
to the maternal-fetal unit, such as preeclampsia, gestational
diabetes mellitus (GDM), infertility, and in vitro fertilization.
Pleskacova et al. compared midgestation and early postpar-
tum vitamin D status in women with GDM versus controls.
They showed that both groups present similarly low 25(OH)D
levels and overall high prevalence of vitamin D deficiency.
However, women with GDM history presented significantly
lower 25(OH)D levels and higher prevalence of 25(OH)D
deficiency postpartum. The above manuscripts suggest that,
despite convincing associations between hypovitaminosis D
and gynecological/obstetric diseases, a causal relationship
needs to be confirmed in future investigations aimed at
clarifying themechanisms linking vitaminDmetabolism and
hormonal/metabolic pathways involved in these diseases.
The study by Kalousova´ et al. readdressed the important
issue of vitamin D status in nondialysis and dialysis CKD
patient. In particular, they studied the relationship between
vitamin D concentration in plasma and vitamin D binding
protein (VDBP). The authors confirmed that plasma levels
of vitamin D are decreased in CKD, especially in dialysis
patients. More importantly, they found that VDBP does not
play a role in vitamin D deficiency because of enhanced pro-
duction as compared with healthy controls that compensates
urinary losses of this protein.
It is known that intracellular calcium concentration
significantly increases in peripheral blood mononuclear cells
(PBMCs) of CKD patients, possibly impairing the regulatory
mechanisms maintaining cellular calcium homeostasis. L.
Sikurova et al. evaluated in early CKD patients with vitamin
D deficiency if treatment with cholecalciferol for 6 months
may restore these abnormalities. They showed that vitamin
D3 supplementation had a beneficial effect on disturbed cell
calcium homeostasis in these patients with early CKD.
The study of K. Sˇebekova´ et al. addressed the question
whether an excessive accumulation of advanced glycation end
products (AGEs) in the skin of diabetic patients interferes
with dermal vitamin D3 formation and whether hypovita-
minosis D is associated with an increased formation and
toxicity of AGEs. They showed that hypovitaminosis D is not
associated either with enhanced AGE accumulation or with
markers of inflammation. These data suggest that hypovita-
minosis D seems to be of limited importance for the develop-
ment of microinflammation and accumulation of AGEs.
As summarized here, the research field on the extraskele-
tal effects of vitaminD is continuously growing. In this special
issue, we tried to give a glimpse, although somehow critical,
of the most interesting studies in this topic. Clinical studies
are however still needed to correctly translate in patients the
results obtained in labs.
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